Absence of detectable striatal dopamine D 4 receptors in drug-treated schizophrenia

By Reynolds G.P.   Mason S.L.  

European Journal of Pharmacology, Vol. 281, Iss. 2, 1995-08 ,pp. : 5-6

Elsevier

Access to resources Recommend Favorite

Striatal dopamine D₂ receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an ¹²³I-IBZM-SPECT study

By Lomeña Francisco   Catafau Ana   Parellada Eduard   Bernardo Miquel   Font Mireia   Gutiérrez Fernando   Pavía Javier  

Psychopharmacology, Vol. 172, Iss. 2, 2004-03 ,pp. : 165-169

Springer Publishing Company

Access to resources Recommend Favorite

REGION-SPECIFIC DECREASE OF DOPAMINE AND ITS METABOLITES IN BRAINS OF MICE GIVEN ERGOTAMINE

By Filipov Nikolay M.   Thompson Frederick N.   Tsunoda Masashi   Sharma Raghubir P.  

Journal of Toxicology and Environmental Health, Vol. 56, Iss. 1, 1999-01 ,pp. : 47-58

Taylor & Francis Ltd

Access to resources Recommend Favorite

Priming of 6-hydroxydopamine-lesioned rats with l-DOPA or quinpirole results in an increase in dopamine D 1 receptor-dependent cyclic AMP production in striatal tissue

By Pinna A.   Morelli M.   Drukarch B.   Stoof J.C.  

European Journal of Pharmacology, Vol. 331, Iss. 1, 1997-07 ,pp. : 23-26

Elsevier

Access to resources Recommend Favorite

Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait

By Mateos Jose   Lomeña Francisco   Parellada Eduard   Mireia Font   Fernandez-Egea Emili   Pavia Javier   Prats Alberto   Pons Francisca   Bernardo Miquel  

Psychopharmacology, Vol. 191, Iss. 3, 2007-04 ,pp. : 805-811

Springer Publishing Company

Access to resources Recommend Favorite